Oral retinoids. What should the prescriber known about their teratogenic hazards among women of child-bearing potential?

Mitchell, A A

Oral retinoids. What should the prescriber known about their teratogenic hazards among women of child-bearing potential? [electronic resource] - Drug safety - 79-85 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review

0114-5916

10.2165/00002018-199207020-00001 doi


Abnormalities, Drug-Induced--epidemiology
Adult
Female
Humans
Infant, Newborn
Isotretinoin--adverse effects
Pregnancy
Retinoids--adverse effects
Teratogens
United States--epidemiology
Vitamin A--adverse effects